Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Unique Handheld Diagnostic Device - First of its Type in the Marketplace

Published: Monday, March 18, 2013
Last Updated: Sunday, March 17, 2013
Bookmark and Share
AgPlus Diagnostics unveils the first working prototype of their unique new handheld system for rapid, on-the-spot diagnostic results.

AgPlus Diagnostics has announced that the first functional prototype of the handheld AgPlus Diagnostics analytical platform is now fully operational and available for demonstration.

Delivering laboratory-grade, quantifiable results within just 10 minutes of sample application the portable AgPlus technology system has enormous potential in a wide variety of applications where a rapid, accurate and sensitive result is important for fast and reliable decision making.

The AgPlus Diagnostics platform utilizes electrochemical immunoassay technology in a patented microfluidic chip format.

The unique signalling and measurement system, based on the detection of amplified silver ions by anodic stripping voltammetry, allows extremely sensitive, accurate and quantifiable results to be obtained from a very small sample volume (50µl) within minutes.

The system does not rely on an optical based detection method, so no sample preparation is required, making it ideal for multiple sample types and for testing in a range of settings.

The first fully functional AgPlus technology prototype will demonstrate an assay for human Troponin I, a cardiac marker used in clinical settings.

The AgPlus Troponin I assay is currently showing a dynamic range of .1ng/ml - 50ng/ml with CVs <20% in a non-optimized format with assay run times of 10 minutes.

In addition, AgPlus tests for cortisol and testosterone are currently in development, which will be of value in sports science applications for developing more tailored training plans for athletes and to help reduce chances of Over Training Syndrome.

The technology has been developed so that it can be applied to new and established chemistries and the platform software is easily integrated into existing information management systems.

AgPlus Diagnostics foresee further potential for this technology in human (clinical and non-clinical) and veterinary diagnostics, as well as in environmental and military applications.

“The first working AgPlus technology system prototype is an important milestone for AgPlus Diagnostics, demonstrating the successful coming together of this novel diagnostic assay and its unique analytical platform to achieve a fully functional, portable system that can deliver accuracy and sensitivity that’s on a par with laboratory analyzers,” comments Chief Executive Officer, Keith Page.

AgPlus Diagnostics is seeking to develop partnerships and licensing agreements with collaborators in a variety of applications and business sectors.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos